Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

4 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-07

Study Completion Date

2022-03-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a project that will determine whether the use of daily bright light therapy has an effect on depressive symptoms experienced by adult inpatients with CF and COPD. The purpose of this project is to apply a daily 30-minute BLT intervention to hospitalized adult CF and COPD patients in order to decrease symptoms of depression as measured by depression inventory scoring.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pilot Trial of Phototherapy for Acute Depression in Hospitalized Cystic Fibrosis Patients

NCT01822197

Depression Cystic Fibrosis

COMPLETED NA

Airway Secretion Clearance in Cystic Fibrosis

NCT00839644

Cystic Fibrosis

TERMINATED NA

Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis

NCT02129803

Cystic Fibrosis

COMPLETED NA

Project UPLIFT to Reduce Anxiety and Depression in CF Patients

NCT03139266

Cystic Fibrosis Anxiety Depression

COMPLETED NA

Determinants of Early Cystic Fibrosis Lung Disease

NCT03579173

Cystic Fibrosis in Children

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This project will occur on a 29-bed pulmonary step-down unit at a 1,600-bed academic medical center. This unit commonly treats patients with CF, COPD, and other pulmonary complications. The unit's patient care staff will be educated on the bright light lamps in order to prevent interruptions and to encourage compliance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cystic Fibrosis Depressive Symptoms Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

This is a non-randomized, single group, pre- and post-intervention project.

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bright Light Therapy (BLT)

The intervention will consist of daily BLT sessions lasting 30 minutes at approximately 10AM (since many CF and COPD patients may not awaken until this time) starting on the day of admission through discharge for a goal of seven consecutive days. The intervention will use a 10,000-lux light box placed approximately 16-24 inches from the patient's face.

Group Type EXPERIMENTAL

Bright Light Therapy (BLT) Lamp

Intervention Type DEVICE

With its built in automatic timer shut-off function, the bedside registered nurse (RN) would not need to return to the room to turn off this lamp after 30 minutes because the lamp will automatically shut off on its own.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bright Light Therapy (BLT) Lamp

With its built in automatic timer shut-off function, the bedside registered nurse (RN) would not need to return to the room to turn off this lamp after 30 minutes because the lamp will automatically shut off on its own.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Verilux HappyLight Luxe - UV-Free LED Therapy Lamp by Verilux

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with cystic fibrosis or chronic obstructive pulmonary disease (COPD)
* Adult age 18 or older
* Admitted to the pulmonary step-down and transplant unit
* Score greater than zero on pre-intervention Beck's Depression Inventory-II (BDI-II)

Exclusion Criteria

* Pre-existing ophthalmological conditions or photosensitivity
* Migraines
* Receiving high dose steroids for transplant rejection (due to mood altering qualities),
* Antibiotics that increase light sensitivity
* Diagnosed with bipolar disorder (light therapy may trigger mania)
* Admissions anticipated to span less than 48 hours
* Children are being excluded due to the fact that only adult CF and COPD subjects are admitted to University of Pittsburgh Medical Center (UPMC) Presbyterian hospital

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No